Reduction of pyramidal and immature hippocampal neurons in pediatric simian immunodeficiency virus infection by Curtis, Kimberly et al.
Reduction of Pyramidal and Immature Hippocampal Neurons in
Pediatric SIV Infection
Kimberly Curtis1, Matthew Rollins1, Heather Carryl1, Kimberly Bradshaw1, Koen K. A. Van
Rompay3, Kristina Abel4, and Mark W. Burke1,2,*
1Department of Physiology & Biophysics, Howard University, Washington D.C., U.S.A
2Department of Psychiatry, Howard University, Washington D.C., U.S.A
3California National Primate Research Center, University of California Davis, Davis California,
U.S.A
4Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, N.C.,
U.S.A
Abstract
Pediatric HIV infection remains a global health crisis with a worldwide infection rate of 2.5
million (WHO, Geneva Switzerland, 2009). Children are much more susceptible to HIV-1
neurological impairments than adults, which is exacerbated by co-infections. A major obstacle in
pediatric HIV research is sample access. The proposed studies take advantage of ongoing pediatric
SIV pathogenesis and vaccine studies to test the hypothesis that pediatric SIV infection diminishes
neuronal populations and neurogenesis in the hippocampus. Newborn rhesus macaques (Macaca
mulatta) that received intravenous inoculation of highly virulent SIVmac251 (n=3) or vehicle
(control n=4) were used in this study. After a 6–18 week survival time, the animals were sacrificed
and the brains prepared for quantitative histopathological analysis. Systematic sections through the
hippocampus were either Nissl stained or immunostained for doublecortin (DCX+), a putative
marker of neurogenesis. Using design-based stereology, we report a 42% reduction in the
pyramidal neuron population of the CA1, CA2, and CA3 fields of the hippocampus (p < 0.05) in
SIV-infected infants. The DCX+ neuronal population was also significantly reduced within the
dentate gyrus of the hippocampus. The loss of hippocampal neurons and neurogenic capacity may
contribute to the rapid neurocognitive decline associated with pediatric HIV infection. These data
suggest that pediatric SIV infection, which leads to significant neuronal loss in the hippocampus
within 3 months, closely models a subset of pediatric HIV infections with rapid progression.
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An estimated 1,500 children under the age of 15 years become infected with HIV-1 daily in
resource poor areas, with most being perinatally infected through mother-to-child-
transmission (MTCT) [1]. Though approximately 100 countries have implemented
prevention of mother to child transmission (PMTCT) of HIV, only an estimated 10% of
pregnant women are offered this service worldwide and less than 6% in resource poor areas.
Perinatal transmission rates in developing nations remain high despite the UNAIDS effort to
eliminate new HIV infections among children by 2015 [1]. Within the United States there is
a perinatal infection rate of 1–3% annually despite early identification and triple anti-
retroviral therapy (ART). The developing immune system is more susceptible than the adult
to adverse viral infections [2] with about 25% of HIV-infected infants dying before their
second birthday [3].
Infants are disproportionately affected by HIV-1 related neurological impairments in
comparison to adults [4, 5]with children often displaying neurobehavioural deficits prior to
significant immunosuppression [6]. Imaging studies from HIV-1 positive children have
shown gross brain disturbances resulting in ventrical enlargement, sulcal widening, white
matter lesions, encephalopathy, global cortical atrophy, basal ganglia calcifications, altered
metabolite concentrations in the frontal cortex and hippocampus and potential demylenation
of the corpus callosum [6–8]. Neurobehavioural deficits suggest dysfunction of the frontal
cortex as well as the hippocampus with affected children presenting a range of fine and
gross motor impairments, cognitive delays, verbal deficits, memory deficits,visual
impairment, abnormal muscle tone, and spasticity [4, 6, 7].
Neonatal rodent models of intracranial HIV-1 tat antigen administration further support
clinical evidence that the neurons of the hippocampus, as well as hippocampal neurogenesis,
are particularly susceptible to the neurotoxic cascade of HIV-1 proteins [9]. Scarce
pathology reports from HIV-infected children have provided evidence of apoptosis in the
cerebral cortex associated with perivascular inflammation [10], but have been limited in
addressing HIV induced neuropathogenesis. Due to the persistent rates of HIV-1 infection in
developing nations (2–4), an assessment of the impact of early HIV-1 infection on brain
development is urgently needed. A significant barrier to pediatric HIV-1 neurological
research is sample access [2].
Non-human primates offer a valid alternative due to the fact that infant macaques show
similar neuroanatomical and immune system development to human infants [2].
Furthermore, human immunodeficiency virus and simian immunodeficiency virus infections
share a similar pathophysiology and MTCT is replicable in monkeys [2]. The pathogenic
uncloned SIVmac251 isolate used in the current study closely models a subset of pediatric
HIV-infection with persistently high virus replication and rapid progression; infant
macaques progress to simian AIDS (SAIDS) within 6 months. In light of the clinical
manifestations of pediatric HIV infection and the effects of HIV-related proteins on the
developing rodent brain we tested the hypothesis that SIV infection deleteriously affects the
integrity of the hippocampus by reducing the pyramidal and immature neuronal populations
in a pediatric model of HIV infection.
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Newborn rhesus macaques (Macacca mulatta) were hand-reared in the nursery of the
California National Primate Research Center (CNPRC) in accordance with American
Association for Accreditation of Laboratory Animal Care Standards. We strictly adhered to
the “Guide for the Care and Use of Laboratory Animals” prepared by the Committee on
Care and Use of Laboratory Animals of the Institute of Laboratory Resources, National
Resource Council. The experimental protocol was reviewed and approved by the University
of California Davis Institutional Animal Care and Use Committee. A total of 7 neonatal
monkeys were randomly assigned to one of two groups (Group 1-control, n=4; Group 2-
SIV infection, n=3). Within 72 hours after birth, subjects in group 2 received intravenous
inoculation with 100 tissue culture doses 50% (TCID50) of SIVmac251 obtained from the
Analytical and Resource Core at CNPRC [2]. Plasma viral loads were quantified by real-
time RT-PCR [11]. Although the dose of this virus inoculum is still higher than how most
human infants acquire perinatal HIV infection, this moderate dose was selected to obtain a
100% infection rate in a well-established animal model of perinatal infection.[2,].
The SIV-infected infants were euthanized between 7 and 10 weeks of age (Table 1) when
they met the established clinical criteria for euthanasia of retrovirus-infected animals
(including symptoms like lethargy, weight loss, dehydration, diarrhea and opportunistic
infections unresponsive to standard treatments). The brains were extracted, post-fixed in
10% formalin, blocked into 1-cm slabs in the coronal plane, cryoprotected in 30% buffered
sucrose, and frozen at −80°C until further processing. Ten parallel series of coronal sections
(50μm) were obtained from each animal with the first series being Nissl stained with cresyl-
violet for design-based stereology. The remaining series were placed in antigen preserve
(50% ethylene glycol, phosphate buffer pH=7.4, and 1% polyvinal pyrrolodone) and stored
at −20°C for future immunohistochemical analysis.
Design-Based Stereology
Total estimation of the pyradimal neuronal population of the hippocampus cornu ammonis
fields (CA1-3) was achieved using the optical fractionator method. Sampling parameters are
similar to previously described methods of design-based stereology in the primate
hippocampus [13]. Briefly, sections topography and superimposed counting frames
(disectors) were generated through the MicroBrightField StereoInvestigator program
(Williston, Vermont, USA) attached to a Nikon Eclipse microscope under 4x (topography)
and 60x (counting objective: Plan Fluor oil-immersion, N.A.=1.4) objectives. For the
stereological parameters in this study every 20th section was selected with a random starting
point within 500μm of the beginning of the CA fields and continued to the CA fields were
no longer visible. Sampling in the absence of a visible dentate gyus granular layer of the
most anterior and posterior regions ensured an estimation of the entire CA hippocampal
neuronal population. The total estimation of pyramidal neuronal numbers (N) was calculated
by the following equation:
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Where ssf is section-sampling fraction, asf is area-sampling fraction, tsf is thickness-
sampling fraction (where the measured thickness of the tissue is divided by the dissector
height), and ΣQ− is total number of objects of interest counted. For this study, a neuron was
defined as having a visible centrally located nucleolus and defined cytoplasm. The average
coefficient of error (CE) for total number of neurons was determined to assess reliability of
measurements.
Immunohistochemistry
A complete series of sections spanning the entire hippocampus area was taken from the
developmental brain bank to undergo doublecortin staining (DCX), a putative marker of
immature neurons [14]. Standard batch immunohistochemical techniques were followed for
the DCX immunohistochemistry. Briefly, free floating sections were rinsed in PBS 3 times,
incubated for 1 hour in a pretreatment (3% hydrogen peroxide, 20% methanol in PBS),
blocked for 1 hour in 3% normal horse serum and then incubated overnight in goat anti-
DCX (1:400 Santa Cruz #sc-8066) at room temperature. The next day, sections were washed
in PBS and incubated in horse anti-goat secondary antibody (1:200, Vector) for 1.5 hours,
followed by 1.5 hours in ABC (Vector) and visualized with DAB (Sigma). Next, sections
were wet-mounted on gelatinized slides and air dried overnight. The following day, sections
were dehydrated in graded ethanol (50–100%), cleared in xylene and coverslipped with
DPX mounting media (VWR Int. Poole, UK).
Statistical analysis
Statistical differences were determined using the Mann-Whitney U test of significance on
the GraphPad InStat3 program (La Jolla, California, USA). The coefficient of variation (CV
= SD/mean), presented in parenthesis was calculated for neuronal numbers and volume
estimation. The CE for the different measurements was calculated as .
Results
One section of every 20th section (SSF) was selected from the entire rostral-caudal extent of
the hippocampus. The first sections were taken from the CA1 subfield, which produced a set
sample of 13–16 sections throughout the rostral-caudal region. Standard scan grid sizes of
500μm × 500μm, 250μm × 250μm, and 350μm × 350μm were used for CA1, CA2, and CA3
respectively. For each disector site a standard 40μm × 40μm × 10μm counting frame was
employed. Section thickness was measured at each counting site with an average measured
thickness of 17.87μm, which provided an average guard height of 3.93μm(Table 2).
Perinatal SIV infection resulted in an overall average of 42% reduction (Figure 1) in the
total number pyramidal neuronal population (p = 0.0286). There were significant neuronal
reductions in the CA1 region (1.106 × 106, CV = 0.05 SIV+ vs 1.996 × 106, CV = 0.145
control), CA2(0.240 × 106, CV = 0.173 SIV+ vs 0.434 × 106, CV = 0.057 control), and
CA3(0.730 × 106, CV = 0.189 SIV+ vs1.182 × 106, CV = 0.174control) in SIV+ versus
control subjects (p = 0.0286 for each group; Figure 1). The estimation of neurons produced a
ratio BCV2/CV2 of greater than 0.85 for both groups indicating low sampling error and a
precise estimate of hippocampal neuronal population.
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Immunostaining of the hippocampus for DCX indicated an observable reduction in
immature neurons of the dentate gyrus. The reduced pattern of DCX+ neurons was apparent
in each SIV+ subject whereas in the control subjects, the density of immature neurons
occluded visible identification of individual neurons (Figure 2).
Discussion
Using a perinatal MTCT non-human primate model to study the neuropathogenesis of SIV
infection, we provide evidence of loss of pyramidal neurons of the CA1-3 fields along with
a dramatic reduction in immature neurons within the first three months of infection. While
much of the clinical research focuses on global cortical changes and the basal ganglia [6–8],
there is increasing evidence of HIV-1 related toxicity in the hippocampus [9, 15–18]. Neural
atrophy of the hippocampus is also reported in young adult monkeys following SIV
infection [19]. Intracranial injections of the HIV-1 associated proteins gp120 and Tat in
neonatal rats have been found to significantly reduce neuronal populations of the CA2 and
CA3 fields of the hippocampus [9, 20] and suppress long-term potentiation of CA1 neurons
[20] which was correlated to declines in spatial memory [9]. Additionally, HIV-1 gene
sequences have been detected in the hippocampus of post-mortem brains [17]
The paucity of hippocampal neurons following neonatal SIV infection provides anatomical
evidence for memory impairments in HIV infected children. Under normal developmental
conditions the pyramidal neuronal population remains stable during the first two years of
life, while neurogenesis in the dentate gyrus peaks during the first three months [13]. Thus
any damage of the hippocampus structure/function will likely result in long-term
neurological consequences as reported in HIV positive children [18]. HIV-1 has been
reported in neural progenitors of archival pediatric brain tissue providing clinical evidence
of an interaction between HIV-1 and neural progenitors [16]. In vitro, both gp120 and Tat
proteins have been found to attenuate proliferation of human neural progenitor cells
(hNPCs) [18]without affecting the viability of pre-existing hNPCs [18]. A novel finding in
this study is the apparent reduction in DCX+ neurons in the dentate gyrus. Whether this
reflects a neurotoxic effect on established immature neurons, an acceleration of the
maturation process as a repair mechanism, or an attenuation of neural progenitor
proliferation remains to be determined.
Neuroinflammation and breakdown of the blood brain barrier (BBB) have been implicated
as mechanisms contributing to HIV-1 related neurological disorders [21–24]. Once the virus
transverses the BBB, its ability to infect cells depends on the presence of CCR5 and
CXCR4, which increases in expression from birth to 9 months of age in the primate
hippocampus [25]. Expression of CD4 receptors and the chemokine co-receptors CCR5 and
CXCR4 play an important role in the pathogenesis of HIV [25] and signaling through these
receptors results in a balance between survival/pro-inflammatory neuronal death [26]. These
receptors are expressed on neural progenitor cells and have been proposed to play a role in
HIV induced reductions in neurogenesis [24, 27]
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The extent of HIV-1 infection of specific cell types, neuronal loss, and its mechanism of
action in infants is currently unknown [6], severely limiting the ability to develop and
evaluate therapeutic paradigms to minimize the neurological impairments as a result of
HIV-1 infection. Proliferating NPCs in the dentate gyrus can be upregulated with the
serotonin specific re-uptake inhibitor paroxetine even in the presence of HIV Tat protein
[18]. Neurobehavioural and cognitive dysfunction remains prevalent in perinatally infected
children even if they receive combination ART [4, 6, 8]. Although ART suppresses
peripheral viral replication, it has a relatively low bioavailability in the central nervous
system thereby allowing the brain to be a viral reservoir and potentially exacerbating
neuropathogenesis of pediatric HIV infection [6]. In order to take advantage of
developmental plasticity in future potential therapeutic interventions aimed at minimizing
neurological impairment by pediatric HIV infection as well as co-infections (e.g.
tuberculosis and malaria), it is necessary to define the response to HIV-1 infection during
the early developmental period.
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Figure 1. Hippocampal Pyramidal Neuronal Population
Neuonal populations were reduced in CA1-3 fields with an reduction in CA1 volume (p<
0.05). SIV infected infants (A–C) displayed gross morphological differences such as
enlarged ventricles and thinned pryamidal layers compared to control subjects (D–F).
Magnifications of 1.25× (A & D), 20× (B & E) and 100× (C & F) are displayed above; scale
bars = 5mm, 200μm, and 50μm respectively.
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Figure 2. DCX+ Immature Neurons
There is an apparent lack of DCX+ neurons observed in the dentate gyrus of SIV+ subjects
(A–C) as compared to control subjects (D–F). Magnifications of 1.25× (A & D), 20× (B &
E) and 100× (C & F) are displayed above; scale bars = 5mm, 200μm, and 50μm
respectively.
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